Drugs |
Specialties
| Education
| Points

Malaysia
Search
Sign In

Pharmacy

Pharmacy

Specialties

Multidisciplinary
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hepatology
Infectious Diseases
Neurology
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Psychiatry
Respirology
Rheumatology
Urology
Pharmacy

Country

China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand

Search

Pharmacy

Medical News
Case Studies
CME
Clinical Review
Practice Insights
Patient Resources
Drug Updates

Special Reports

Specialties

Multidisciplinary
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hepatology
Infectious Diseases
Neurology
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Psychiatry
Respirology
Rheumatology
Urology
Pharmacy

China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand

Drugs |
Specialties
| Education
| Points

Home News Conferences Special Reports Multimedia

Medical News
Case Studies
CME
Clinical Review
Practice Insights
Patient Resources
Drug Updates

Product Highlight - Amnoz

30 Nov 2022

YOUR CHOICE FOR BETTER BLOOD PRESSURE CONTROL
• Available in 5 mg and 10 mg
• First-line treatment for hypertension and angina
• Long half-life at 30 to 50 hours and is consistent with once-daily dosing
• Bioequivalent to the originator

References:
•Amnoz Tablet 5 mg, 10 mg Package Insert, July 2021.
•Integrated Study Report for Oral Bioequivalence study of Pharmaniaga Amlodipine 10 mg tablet, Pharmaniaga Manufacturing Berhad, Malaysia and Norvasc (amlodipine) 10 mg tablet of Pfizer Australia Pty. Ltd., Australia, in healthy, adult, human subjects under fasting condition.
•Fares H, DiNicolantonio JJ, O’Keefe JH, et al. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. 2016.

Editor's Recommendations

Pharmacy

Specialties

Multidisciplinary
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hepatology
Infectious Diseases
Neurology
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Psychiatry
Respirology
Rheumatology
Urology
Pharmacy

News

Medical News
Case Studies
CME
Clinical Review
Practice Insights
Patient Resources
Drug Updates

Conferences

Conferences Report

More Services

Drugs
Specialties
Education
Points
Subscribe

About

MIMS Corporate
Term of Use
Privacy Policy
Feedback

Connect With MIMS

Copyright © 2023 MIMS Pte Ltd. All rights reserved.